Asian markets are down despite Trump's tariff pause, ending a brief relief rally. Investors remain wary due to ongoing ...

Argenx (ARGX) announced that the U.S. Food and Drug Administration approved a new option for patients to self-inject VYVGART Hytrulo with a ...

Texas Capital analyst Eric Wold initiated coverage of Brunswick (BC) with a Hold rating and $54 price target Stay Ahead of the Market: ...

Bearish flow noted in 3M (MMM) with 3,978 puts trading, or 1.0x expected. Most active are Jun-25 145 puts and Jun-25 140 puts, with total ...

Bullish option flow detected in Halliburton (HAL) with 8,124 calls trading, 1.1x expected, and implied vol increasing over 11 points to 65.61%.

In a report released yesterday, Eve Burstein from Bernstein maintained a Hold rating on Agilent (A – Research Report), with a price target of ...

CIBC analyst Jamie Kubik lowered the firm’s price target on Freehold Royalties (FRHLF) to C$15 from C$16 and keeps a Neutral rating on the ...

Barclays analyst Lydia Rainforth maintained a Buy rating on Equinor ASA (0M2Z – Research Report) today and set a price target of NOK400.00. The ...

In a report released today, Andrew Mok CFA from Barclays maintained a Buy rating on Radnet (RDNT – Research Report), with a price target of ...

The 2025 whitepaper from License Global highlights the brand licensing agents that are facilitating consumer product growth ...

Palantir has been through the wringer lately. The AI darling that once soared to dizzying heights has been experiencing ups ...

Turning to Wall Street, analysts have a Moderate Buy consensus rating on PYPL stock based on 16 Buys and 15 Holds ...